Medical Advisors

Solid Tumor Advisors

Jordan D. Berlin, M.D.

Co-Leader, Gastrointestinal Cancer Research Program, Professor of Medicine (Hematology/Oncology), Director, Phase I Program, Medical Oncologist, Vanderbilt-Ingram Cancer Center

J. Randolph Hecht, M.D.

Director, Gastrointestinal Cancer Program, Professor of Clinical Medicine, David Geffen School of Medicine at UCLA

Heloisa P. Soares, M.D., Ph.D.

Section leader, HPB cancers and NETs clinical program, University of New Mexico Comprehensive Cancer Center

Josep Tabernero M.D., Ph.D.

Head, Medical Oncology Dept, the Vall d´Hebron University Hospital. Director, Vall d´Hebron Institute of Oncology (VHIO), Barcelona Area, Spain

Eric Van Cutsem, M.D., Ph.D.

Medical Doctor and Professor of Medicine (Digestive Oncology) at University Hospital Gasthuisberg/Leuven, Belgium

Acute Myeloid Leukemia Advisors

Jorge Cortes, M.D.

Acute Myeloid Leukemia Advisor

Director of The Georgia Cancer Center at Augusta University. He is designated as a Georgia Research Alliance Eminent Scholar in Cancer in the Medical College of Georgia.

Bayard L. Powell, M.D.

Section Chief, Hematology & Oncology, Associate Director for Clinical Research, Comprehensive Cancer Center, Professor, Hematology & Oncology, Wake Forest Baptist Medical Center

Mikkael Sekeres, M.D.

Director, Leukemia Program, Vice-chair for Clinical Research, Cleveland Clinic’s Taussig Cancer Institute

Richard M. Stone, M.D.

Professor of Medicine, Harvard Medical School; Associate Physician, Medicine, Brigham And Women’s Hospital; Director, Adult Leukemia Program, Dana-Farber Cancer Institute

Lymphoma Advisors

Craig H. Moskowitz, M.D.

Physician in Chief, Oncology Service Line, Sylvester Comprehensive Cancer Center Professor, Department of Medicine

Ariela Noy, M.D.

Attending Physician and Member: Hematology Divistion/Lymphoma Service; Memorial Sloan-Kettering Cancer Center; Chair of the Lymphoma Working Group for the AIDS Malignancy Consortium

Steven I. Park, M.D.

Lymphoma Advisor

Division Chief, Hematology and Oncology, Levine Cancer Institute, CHS-Northeast; Director of Investigational Therapeutics in Hematologic Malignancies, Levine Cancer Institute/Carolinas HealthCare System; Associate Professor of Medicine, University of North Carolina, Chapel Hill